Form 4: BioLargo President Converts Debt to Equity, Acquires 169,498 Shares Under Lock-Up

BioLargo, Inc.'s President and Director, Dennis P. Calvert, acquired 169,498 shares of common stock at $0.2 per share by converting outstanding salary and expense debt, with the shares subject to a lock-up until specific revenue or market capitalization targets are met.

Summary

• Dennis P. Calvert, President and Director of BioLargo, Inc. (BLGO), acquired 169,498 shares of common stock on July 14, 2025.
• The shares were acquired at a price of $0.2 per share.
• This acquisition was in exchange for a reduction in amounts owed by BioLargo to Mr. Calvert for salary and unreimbursed business expenses.
• The acquired shares are subject to a Lock-Up Agreement, restricting their sale until BioLargo reports gross revenue of at least $40 million on a consolidated basis for any reported period, or its market capitalization exceeds $300 million, or there is a 'change in control' in the Issuer.
• Following this transaction, Mr. Calvert beneficially owns 10,029,542 shares, including 1,528,695 shares owned indirectly through a limited liability company.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key insider, even through debt conversion, generally signals confidence in the company's future. The lock-up agreement further aligns management's interests with long-term growth targets, which is a positive for shareholders. However, the low share price of the transaction and the restrictive lock-up conditions temper the overall positive sentiment.

Positives

• Insider (President and Director) acquiring additional shares, indicating confidence in the company's future prospects.
• Conversion of debt (salary and expenses owed to the reporting person) into equity, which reduces the company's liabilities.
• The lock-up agreement aligns the insider's interests with long-term company performance and growth targets ($40 million revenue or $300 million market capitalization).

Negatives

• The acquired shares are subject to a lock-up agreement, meaning they cannot be sold until specific financial or control conditions are met, limiting immediate liquidity for the reporting person.
• The acquisition price of $0.2 per share is relatively low, which might reflect the current valuation of the company.

Risks

• The lock-up conditions (achieving $40 million in gross revenue or $300 million market capitalization) are significant hurdles, and failure to meet these targets could indefinitely restrict the sale of the acquired shares.
• The value of the acquired shares is tied to the company's future performance and market valuation, which are subject to market risks.

Future Outlook

The lock-up agreement ties the liquidity of the acquired shares to future financial performance, specifically achieving $40 million in consolidated gross revenue or a $300 million market capitalization, indicating management's focus on these growth targets.

Industry Context

This is an insider transaction, common in publicly traded companies, reflecting a director's or officer's direct investment or debt conversion into company equity. It is a standard practice in corporate finance and governance.

Comparison to Industry Standards

• NA. This document is an SEC Form 4 detailing an insider transaction, not a financial performance report that would typically be compared to industry benchmarks or specific comparable companies/projects.

Corporate Governance

Related Party Transactions

• Acquisition of 169,498 shares of common stock by Dennis P. Calvert, President and Director, from BioLargo, Inc. in exchange for a reduction in salary and unreimbursed business expenses owed by the Issuer to Mr. Calvert.

Stakeholder Impact

• Shareholders: Increased insider ownership may signal management confidence, potentially positively influencing investor sentiment. The debt-to-equity conversion reduces company liabilities.
• Creditors: The conversion of debt to equity reduces the company's outstanding liabilities, which could be viewed favorably by creditors.

Next Steps

• Achieve consolidated gross revenue of at least $40 million for any reported period to release shares from lock-up.
• Increase market capitalization to exceed $300 million to release shares from lock-up.
• Potential 'change in control' in the Issuer could also release shares from lock-up.

Key Dates

Recommendation

Keywords

SEC Form 4, insider transaction, stock acquisition, debt conversion, BioLargo, BLGO, lock-up agreement, corporate governance, equity, director, officer